Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?
Bioengineered 2021 William E. Gibbons, Madeline G. Mckinney, Philip J. O’dell et al. 8 citations
Psilocybin, a drug most commonly recognized as a recreational psychedelic, is quickly gaining attention as a promising therapy for an expanding range of neurological conditions, including depression, anxiety, and addiction. This growing interest has led to many recent advancements in psilocybin synthesis strategies, including multiple in vivo fermentation-based approaches catalyzed by...